1. Design, synthesis and biological evaluation of novel isoniazid hybrids
- Author
-
R. Nalini, G.Y. Nagesh, S.M. Basavarajaiah, and K. Ramakrishna Reddy
- Subjects
Chemistry ,medicine.drug_class ,Organic Chemistry ,Isoniazid ,Antimycobacterial ,Combinatorial chemistry ,Corpus albicans ,Inorganic Chemistry ,Acetic anhydride ,chemistry.chemical_compound ,Yield (chemistry) ,Drug Discovery ,Electrochemistry ,medicine ,Physical and Theoretical Chemistry ,Antibacterial activity ,Biological evaluation ,medicine.drug ,Hybrid - Abstract
We herein report the design and synthesis of novel isoniazid derivatives. Isoniazid derived Schiff bases (3 a-d) were subjected to cyclization with acetic anhydride and sulphuric acid to yield the 5′-substituted-3′-acetyl-5-(pyridin-4-yl)-3H-spiro[indole-3, 2-[1′, 3′, 4’]oxadiazol]-2′-yl acetates (4 a-d) and 8′-substituted-3’-(pyridin-4-yl)[1′,3′,4’]oxadiazino[6,5-b]indoles (5 a-d) respectively. The advantages of spectral methods were used for the confirmation of the structure of all the newly synthesized hybrid molecules. Further, these compounds were evaluated for their antibacterial activity against B. Subtilis, S. aureus, E. coli & S. typhi, antifungal activity against C. albicans, C. oxysporum, A. Flavus & A. niger, and antimycobacterial activity against M. tuberculosis. Amongst, the compounds 4b, 4c and 5c were showed excellent inhibitory activity against tested microorganisms. Also, the DNA cleavage activity of selected compounds was carried out by the AGE method.
- Published
- 2022
- Full Text
- View/download PDF